Blog
RSS FeedPosted by Michael Wonder on 19 Aug 2023
Blue Shield of California looks to cut reliance on CVS, taps Amazon
17 August 2023 - Blue Shield of California plans to stop using most of CVS Health's pharmacy benefit management services ...
Posted by Michael Wonder on 16 Mar 2023
ICER publishes white paper on using comparative effectiveness research to address prescription drug spending in California
16 March 2023 - State policy makers and purchasers in California are uniquely positioned to further integrate comparative effectiveness research ...
Posted by Michael Wonder on 21 Jan 2023
Assessing and extending California’s insulin manufacturing initiative
19 January 2023 - Set against the backdrop of current debates about lowering drug costs, lowering the price of insulin—a lifesaving ...
Posted by Michael Wonder on 17 Jan 2023
California sues largest US insulin manufacturers and PBMs for overpricing
16 January 2023 - Eli Lilly, Novo Nordisk and Sanofi produce over 90% of the global insulin supply. ...
Posted by Michael Wonder on 20 Oct 2022
ICER evaluates drug price increases in California
20 October 2022 - Unsupported Price Increase” final report based on drugs identified through SB-17, the California drug price transparency law. ...
Posted by Michael Wonder on 11 Jul 2022
U.S. California will start making its own insulin to combat high drug prices, governor says
8 July 2022 - California Gov. Gavin Newsom announced Thursday that he approved a budget that allocates $100 million for ...
Posted by Michael Wonder on 16 Mar 2022
ICER publishes research protocol for assessing price increases of prescription drugs in California
16 March 2022 - Final assessment to be published on 13 October; drugs to be evaluated are those identified through California’s ...
Posted by Michael Wonder on 03 Mar 2022
ICER to develop a California state unsupported price increase report funded by the California Health Care Foundation
3 March 2022 - Expanded funding supports the development of two annual “Unsupported Price Increase” reports specific to drugs identified through ...
Posted by Michael Wonder on 02 Feb 2022
Universal health care bill fails to pass in California
1 February 2022 - A bill that would have created the nation's only universal health care system has failed to pass ...
Posted by Michael Wonder on 21 Oct 2020
California plans to review coronavirus vaccine independently
19 October 2020 - California is planning to review federally approved coronavirus vaccines independently before distributing it to residents, Governor ...
Posted by Michael Wonder on 29 Sep 2020
California to use market power in bid to lower prescription drug costs
28 September 2020 - California will attempt to use its massive market power to increase the availability and lower the ...
Posted by Michael Wonder on 03 Sep 2020
California may be the first state to develop its own generic drugs
1 September 2020 - California is poised to become the first state to develop its own line of generic drugs, ...
Posted by Michael Wonder on 28 Apr 2020
California fines more than a dozen drug makers for not providing drug pricing data
28 April 2020 - Over the past six months, California state authorities fined more than a dozen drug makers a ...
Posted by Michael Wonder on 09 Jan 2020
California plan would upend drug prices, though obstacles abound
9 January 2020 - Newsom wants to create state-run wholesaler, pool buying power. ...
Posted by Michael Wonder on 09 Jan 2020
California eyes selling its own brand of generic prescription drugs to battle high costs
9 January 2020 - California would become the first state to sell its own brand of generic prescription drugs in ...